Headline
The latest stories from AHA Today.
Avid Medical has recalled several of its medical convenience kits due to fungal contamination risk from an applicator used to sanitize skin before surgery or catheter procedures, the Food and Drug Administration announced.
The Food and Drug Administration authorized for emergency use a new drug to treat hospitalized patients receiving systemic corticosteroids who require supplemental oxygen, mechanical ventilation or extracorporeal membrane oxygenation.
U.S. health care providers may no longer order the monoclonal antibodies bamlanivimab and etesevimab until further notice due to rising prevalence of the SARS-CoV-2 P.1 and B.1.351 variants, which are not susceptible to the combination therapy, the Department of Health and Human Services’ Office of…
Responding to a June 20 op-ed published in the Washington Post, AHA President and CEO Rick Pollack said the alarmist headline misrepresented the facts.
A bipartisan group in the Senate reached a deal with President Biden on a $1.2 trillion infrastructure framework that forgoes tax increases as a funding source.
EmPATH — Emergency Psychiatric Assessment, Treatment and Healing — is a new approach designed to guide patients safely through a current mental health crisis while building coping skills that will guide them through future challenges, writes Lewis Zeidner, system director, clinical triage and…
In a recent Fox Business Network interview, John Riggi, AHA’s senior advisor for cybersecurity and risk offered solutions to help prevent cyberattacks against hospitals and health systems, including investment in new technology and educating the workforce.
The Infectious Diseases Clinical Research Consortium has begun enrolling up to 1,000 pregnant and postpartum individuals who have or will receive COVID-19 vaccine in a study to assess vaccine safety, immune response and transfer of antibodies to their infants, the National Institutes of Health…
The Federal Communications Commission’s Rural Health Care Program will carry forward up to $379.97 million in unused funds from prior years to increase available funding for funding year 2021 and beyond if needed, the agency announced.
The House Energy and Commerce Committee held a hearing on several AHA-supported bills to advance public health by focusing on social determinants of health and data collection.